Drugs / Aminosalicylic acid
Aminosalicylic acid
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | NEOPASALATE | — | 1975-08-12 | fda.gov ↗ |
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02128308 | Nov → Dec 2013 | — | Seoul National University Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00000796 | ? → Oct 1998 | HIV infectious disease, pulmonary tuberculosis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05684484 Comparator | Feb 2023 → Apr 2024 | ulcerative colitis | Tanta University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aminosalicylic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000796 ↗ |
| Known as | P-aminosalicylic acid | “P-aminosalicylic acid(PAS) 2 pack bid” NCT02128308 ↗ |
| Known as | PAS | “P-aminosalicylic acid(PAS) 2 pack bid” NCT02128308 ↗ |